About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

Hong Kong-listed biotechnology stocks continued their strong performance, with Laikai Pharmaceutical (02105.HK) and CanSino Biologics (06185.HK) rising over 20%, Beihai Kangcheng (01228.HK) rising over 14%, and Xuanzhu Bio-B (02575.HK) and Biocytogen

2026-09-30

Hong Kong-listed biotechnology stocks continued their strong performance, with Laikai Pharmaceutical (02105.HK) and CanSino Biologics (06185.HK) rising over 20%, Beihai Kangcheng (01228.HK) rising over 14%, and Xuanzhu Bio-B (02575.HK) and Biocytogen-B (02315.HK) rising 8%.

Other News
2026-09-30

The China Association of Automobile Manufacturers said media reports that Germany and France are drafting a joint paper urging the European Commission to adopt a US-style '301' unilateral trade instrument. The association called such a tool protectio

The China Association of Automobile Manufacturers said media reports that Germany and France are drafting a joint paper urging the European Commission to adopt a US-style '301' unilateral trade instrument. The association called such a tool protectionist and unilateral, saying it would not solve Europe's industry transition challenges, would materially affect Chinese auto and battery sectors, and could disrupt China-EU trade and global auto supply chains. It said it is highly concerned and will firmly support the Chinese government taking necessary countermeasures to defend the legal rights of China’s auto industry and preserve a fair, non-discriminatory international trade environment if the EU proceeds.
2026-09-30

EIA data showed U.S. Midwest gasoline inventories fell last week to historic lows.

EIA data showed U.S. Midwest gasoline inventories fell last week to historic lows.
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2026 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.